120 related articles for article (PubMed ID: 1666112)
1. Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents.
Neyts J; Snoeck R; Schols D; Himpens B; De Clercq E
J Virol Methods; 1991 Nov; 35(1):27-38. PubMed ID: 1666112
[TBL] [Abstract][Full Text] [Related]
2. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
van der Strate BW; De Boer FM; Bakker HI; Meijer DK; Molema G; Harmsen MC
Antiviral Res; 2003 Apr; 58(2):159-65. PubMed ID: 12742576
[TBL] [Abstract][Full Text] [Related]
3. Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations.
Baldanti F; Biron KK; Gerna G
J Infect Dis; 1998 Mar; 177(3):823-4. PubMed ID: 9498475
[No Abstract] [Full Text] [Related]
4. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Snoeck R; Andrei G; De Clercq E
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
[TBL] [Abstract][Full Text] [Related]
5. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
6. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors.
Bedard J; May S; Barbeau D; Yuen L; Rando RF; Bowlin TL
Antiviral Res; 1999 Feb; 41(1):35-43. PubMed ID: 10321577
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.
Bidanset DJ; Rybak RJ; Hartline CB; Kern ER
Antiviral Res; 2004 Jul; 63(1):61-4. PubMed ID: 15196821
[TBL] [Abstract][Full Text] [Related]
8. Screening with a shell vial assay for antiviral activity against cytomegalovirus.
Telenti A; Smith TF
Diagn Microbiol Infect Dis; 1989; 12(1):5-8. PubMed ID: 2540934
[TBL] [Abstract][Full Text] [Related]
9. Progress in understanding cytomegalovirus drug resistance.
Emery VC
J Clin Virol; 2001 Jun; 21(3):223-8. PubMed ID: 11397658
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
Snoeck R; Lagneaux L; Delforge A; Bron D; Van der Auwera P; Stryckmans P; Balzarini J; De Clercq E
Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):615-9. PubMed ID: 2170136
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Takahashi K
Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
Maggs DJ; Clarke HE
Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir.
Harada K; Eizuru Y; Isashiki Y; Ihara S; Minamishima Y
Arch Virol; 1997; 142(2):215-25. PubMed ID: 9125039
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy.
Ducancelle A; Belloc S; Alain S; Scieux C; Malphettes M; Petit F; Brouet JC; Sanson Le Pors MJ; Mazeron MC
J Clin Virol; 2004 Apr; 29(4):241-7. PubMed ID: 15018851
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
Cherrington JM; Fuller MD; Lamy PD; Miner R; Lalezari JP; Nuessle S; Drew WL
J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243
[TBL] [Abstract][Full Text] [Related]
18. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
Plosker GL; Noble S
Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024
[TBL] [Abstract][Full Text] [Related]
19. Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
Kiehl MG; Basara N
Blood; 2001 Sep; 98(5):1626; author reply 1628. PubMed ID: 11547768
[No Abstract] [Full Text] [Related]
20. Value of animal models to evaluate agents with potential activity against human cytomegalovirus.
Kern ER
Transplant Proc; 1991 Jun; 23(3 Suppl 3):152-5, discussion 155. PubMed ID: 1648821
[No Abstract] [Full Text] [Related]
[Next] [New Search]